CeQur Simplicity

CeQur SA focuses on the development and commercialization of innovative insulin delivery systems aimed at improving the management of type 2 diabetes. The company is creating the CeQur Insulin Infuser, a discreet and user-friendly device that allows patients to receive both basal and bolus insulin over a three-day period. This technology is designed to facilitate compliance with intensive insulin therapy, providing users with greater flexibility and reducing the reliance on multiple daily injections. Founded in January 2008 as a spin-off from Danfoss A/S, CeQur is headquartered in Montreux, Switzerland, with additional operations in Nordborg, Denmark, and Marlborough, Massachusetts.